Thoracic Surgery Unit, Donostia Hospital, San Sebastian, Spain.
Eur J Surg Oncol. 2011 Sep;37(9):786-90. doi: 10.1016/j.ejso.2011.05.014. Epub 2011 Jul 2.
To analyse patient survival after the resection of lung metastases from colorectal carcinoma and specifically to verify whether presence of liver metastasis prior to lung metastasectomy affects survival.
All patients who, between 1998 and 2008, underwent lung metastasectomy due to colorectal cancer were included in the study. Kaplan-Meier survival analysis was performed with the log-rank test and Cox regression multivariate analysis.
During this period, 101 metastasectomies were performed on 84 patients. The median age of patients was 65.4 years, and 60% of patients were male. The 30-day mortality rate was 2%, and incidence of complications was 7%. The overall survival was 72 months, with 3-and 5-year survival rates of 70% and 54%, respectively. A total of 17 patients (20%) had previously undergone resection of liver metastasis. No significant differences were found in the distribution of what were supposed to be the main variables between patients with and without previous hepatic metastases. Multivariate analysis identified the following statistically significant factors affecting survival: previous liver metastasectomy (p = 0.03), tumour-infiltrated pulmonary lymph nodes (p = 0.04), disease-free interval ≥ 48 months (p = 0.03), and presence of more than one lung metastasis (p < 0.01). In patients with previous liver metastasis, the shorter the time between primary colorectal surgery and the hepatectomy, the lower the survival rate after pulmonary metastasectomy (p = 0.048).
A previous history of liver metastasis shortens survival after lung metastasectomy. The time between hepatic resection and lung metastasectomy does not affect survival; however, patients with synchronous liver metastasis and colorectal neoplasia have poorer survival rates than those with metachronous disease.
分析结直肠癌肺转移切除术后患者的生存情况,特别是验证肺转移瘤切除术前是否存在肝转移对生存的影响。
本研究纳入了 1998 年至 2008 年间因结直肠癌行肺转移瘤切除术的所有患者。采用 Kaplan-Meier 生存分析进行对数秩检验和 Cox 回归多因素分析。
在此期间,对 84 例患者的 101 例转移瘤进行了切除术。患者的中位年龄为 65.4 岁,60%为男性。30 天死亡率为 2%,并发症发生率为 7%。总生存率为 72 个月,3 年和 5 年生存率分别为 70%和 54%。共有 17 例(20%)患者先前接受过肝转移瘤切除术。有和没有先前肝转移的患者之间,主要变量的分布没有显著差异。多因素分析确定了以下对生存有统计学意义的影响因素:先前的肝转移瘤切除术(p=0.03)、肿瘤浸润性肺淋巴结(p=0.04)、无病间隔时间≥48 个月(p=0.03)和存在多个肺转移灶(p<0.01)。在有先前肝转移的患者中,原发性结直肠癌手术和肝切除术之间的时间越短,肺转移瘤切除术后的生存率越低(p=0.048)。
先前的肝转移史缩短了肺转移瘤切除术后的生存时间。肝切除术和肺转移瘤切除术之间的时间不影响生存;然而,同时患有肝转移和结直肠肿瘤的患者比患有异时性疾病的患者生存率更低。